323
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Screening for Renal Impairment in Viral Hepatopathy B: It is Time to Begin

ORCID Icon, , , ORCID Icon, , , , , & show all
Article: FSO886 | Received 12 Feb 2023, Accepted 12 Jun 2023, Published online: 05 Jul 2023

References

  • BonaviaA , SingbartlK. Kidney injury and electrolyte abnormalities in liver failure. Semin. Respir. Crit. Care Med.39(5), 556–565 (2018).
  • WongF. Liver and kidney diseases. Clin. Liver Dis.6(4), 981–1011 (2002).
  • FlintA. Clinical report on hydro-peritoneum, based on an analysis of forty-six cases. Am. J. Med. Sci.45(90), 306–339 (1863).
  • AttaMG , FineDM. Editorial comment: tenofovir nephrotoxicitythe disconnect between clinical trials and real-world practice. AIDS Read.19, 118–119 (2009).
  • TerrierBenjamin , CacoubPatrice. Virus de l'hépatite B, manifestations extrahépatiques immunologiques et risque de réactivation virale. Rev. Med Int.32(10), 622–627 (2011).
  • VerhelstD , MongeM , MeynardJL , FouquerayB , MougenotB , GirardPM. Fanconi syndrome and renal failure induced by tenofovir: a first case report. Am. J. Kidney Dis.40, 13311333 (2002).
  • NathalieP. Guide du parcours de soins – Maladie rénale chronique de l'adulte (MRC). 85 Haute Autorité de santé – 2021 – ISBN : 978-2-11-162629-4 (2021).
  • European Association for Study of Liver, Association Latino Americana para el Estudio del Higado. EASL-ALEH Clinical Practice Guidelines: non-invasive tests for evaluation of liver disease severity and prognosis. J. Hepatol.63(1), 237–264 (2015).
  • European Association for the Study of the Liver. Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update. J. Hepatol.75(3), 659–689 (2021).
  • Haute Autorité de Santé / Service Évaluation des actes professionnels. Rapport albuminurie/creatininurie- Rapport d'évaluation. (2011). www.has-sante.fr/upload/docs/application/pdf/2011-12/rapport__albuminurie_creatininurie_2011-12-27_14-57-31_440.pdf
  • Groupe de travail de la Société de néphrologie. Évaluation de la fonction rénale et de la protéinurie pour le diagnostic de la maladie rénale chronique chez l'adulte. Recommandations pour la pratique clinique. Nephrol. Ther.5(4), 302–305 (2009).
  • European Association For The Study Of The Liver. EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J. Hepatol.57(1), 167–185 (2012).
  • SéhonouJ , KpossouAR , AmandaTO , SokponCNM , VignonRK , ViganJ. Hépatite virale B et insuffisance rénale: prévalence et facteurs associés au Centre National Hospitalier et Universitaire de Cotonou. Pan. Afr. Med. J.31, 121 (2018).
  • ZhangJH , LiLS , ZhouH. Is there a hepatitis B virus-associated glomerulonephritis? Identification of HBsAG, HBcAG and HBeAG in kidney with monoclonal antibodies. Chin. Med. J.102(7), 496–504 (1989).
  • HeXY , FangLJ , ZhangYE , ShengFY , ZhangXR , GuoMY. In situ hybridization of hepatitis B DNA in hepatitis B-associated glomerulonephritis. Pediatr. Nephrol. Berl. Ger.12(2), 117–120 (1998).
  • FabriziF , DonatoFM , MessaP. Association between hepatitis B virus and chronic kidney disease: a systematic review and meta-analysis. Ann. Hepatol.16(1), 21–47 (2017).
  • TsaiMC , ChenCH , TsengPLet al.Does Nucleos(t)ide analogues treatment affect renal function in chronic hepatitis B patients who have already decreased eGFR? A Longitudinal Study. PLOS ONE11(3), e0149761 (2016).
  • LiuY , ShiC , FanJ , WangB , LiG. Hepatitis B-related glomerulonephritis and optimization of treatment. Expert. Rev. Gastroenterol. Hepatol.14(2), 113–125 (2020).
  • AmetS , Launay-VacherV , PolSet al.Prévalence des anomalies rénales dans l'hépatite B chronique: résultats de l'étude HARPE. Néphrologie. Thérapeutique.8(5), 406–407 (2012).
  • KongXL , MaXJ , SuH , XuDM. Relationship between occult hepatitis B virus infection and chronic kidney disease in a Chinese population-based cohort. Chronic Dis. Transl. Med.2(1), 55–60 (2016).
  • CaiJ , FanX , MouLet al.Association of reduced renal function with hepatitis B virus infection and elevated alanine aminotransferase. Clin. J. Am. Soc. Nephrol.7(10), 1561–1566 (2012).
  • CaiQC , ZhaoSQ , ShiTD , RenH. Relationship between hepatitis B virus infection and chronic kidney disease in Asian populations: a meta-analysis. Ren. Fail.38(10), 1581–1588 (2016).
  • FabriziF , CeruttiR , RidruejoE. Hepatitis B virus infection as a risk factor for chronic kidney disease. Expert. Rev. Clin. Pharmacol.12(9), 867–874 (2019).
  • LiuY , WangX , XuFet al.Risk factors of chronic kidney disease in chronic hepatitis b: a hospital-based case–control study from China. J. Clin. Transl. Hepatol.10(2), 238–246 (2022).